Table 1.

Patient clinical characteristics

MedianRange or %
Age, y5942-81
Sex10 males/8 femalesNA
BM, %12.52.5-80
sIgM, mg/dL2625610-5620
Hb, g/dL11.08.1-14.4
Adenopathy9 (50%)NA
Splenomegaly7 (38.8%)NA
Prior therapies10-4
Untreated, n844.4%
Previously treated, n1055.5%
 Rituximab monotherapy220.0%
 Alkylators770.0%
 Nucleoside analogs550.0%
 Proteasome inhibitors550.0%
  • Hb, hemoglobin; NA, not available; sIgM, serum IgM.